A study of initial therapy for glaucoma in southern India: India Glaucoma Outcomes and Treatment (INGOT) Study

Ophthalmic Epidemiol. 2012 Jun;19(3):149-58. doi: 10.3109/09286586.2012.667493.

Abstract

Purpose: To compare initial glaucoma therapy with medications and trabeculectomy in southern India.

Methods: Patients aged ≥ 30 years newly diagnosed with glaucoma were randomized to trabeculectomy with 5-fluorouracil or medical therapy. Subjects with best-corrected vision <6/18 due to cataract underwent phacoemulsification (phaco/intraocular lens, IOL). Intraocular pressure (IOP), vision and visual function were assessed at 12 months.

Results: Patients assigned to medications and surgery received the expected therapy in 86% (172/199) and 64% (126/199) of cases, respectively. Forty patients (20%) assigned to surgery refused any treatment and 33 (17%) received medications. Among 199 patients randomized to medications, 52 (26.1%) underwent phaco/IOL, as did 89/199 (43.7%) of patients randomized to trabeculectomy. Baseline parameters of the two groups did not differ, nor did 1-year follow-up rates (medication 65%, trabeculectomy 58%, P = 0.15). Final IOP was lower with randomization to trabeculectomy (16.3 ± 5.1 mmHg) than medication (18.8 ± 6.7 mmHg, P < 0.0001). In regression models, randomization to trabeculectomy (P < 0.0001) was associated with lower IOP, and simultaneous trabeculectomy and cataract surgery was associated with higher IOP (P = 0.008) than trabeculectomy alone. Subjects receiving Phaco/IOL had significantly better final acuity (P < 0.0001) and visual function (P = 0.035), despite concurrent glaucoma treatment. Final visual acuity was worse in those receiving trabeculectomy in addition to cataract surgery, but this was of borderline significance (P = 0.06).

Conclusions: Trabeculectomy lowered IOP significantly more than medical treatment, but with slightly greater loss of visual acuity. Combined phaco/IOL and trabeculectomy improved visual acuity with substantial IOP lowering.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Antimetabolites, Antineoplastic / administration & dosage
  • Brimonidine Tartrate
  • Drug Combinations
  • Female
  • Fluorouracil / administration & dosage
  • Glaucoma / drug therapy*
  • Glaucoma / physiopathology
  • Glaucoma / surgery*
  • Humans
  • India
  • Intraocular Pressure / physiology
  • Latanoprost
  • Lens Implantation, Intraocular
  • Male
  • Middle Aged
  • Phacoemulsification
  • Prospective Studies
  • Prostaglandins F, Synthetic / therapeutic use
  • Quinoxalines / therapeutic use
  • Sulfonamides / therapeutic use
  • Surveys and Questionnaires
  • Thiophenes / therapeutic use
  • Timolol / therapeutic use
  • Tonometry, Ocular
  • Trabeculectomy*
  • Visual Acuity / physiology

Substances

  • Antihypertensive Agents
  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • Prostaglandins F, Synthetic
  • Quinoxalines
  • Sulfonamides
  • Thiophenes
  • dorzolamide-timolol combination
  • Brimonidine Tartrate
  • Latanoprost
  • Timolol
  • Fluorouracil